US 11352356
Inhibitors of plasma kallikrein and uses thereof
granted A61PA61P29/00A61P9/00
Quick answer
US patent 11352356 (Inhibitors of plasma kallikrein and uses thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P29/00, A61P9/00